Brigatinib can inhibit proliferation and induce apoptosis of human immortalized keratinocyte cells
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1220196
下载链接
链接失效反馈官方服务：
资源简介：
Brigatinib, one of the second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (ALK-TKIs), is approved for the treatment of patients with ALK-positive non-small cell lung cancer (NSCLC).
创建时间：
2025-02-06
